Drawing for ADAPTIVE INTELLIGENCE

USPTO serial 87892674

ADAPTIVE INTELLIGENCE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SONNEBORN, TRICIA L
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with ADAPTIVE INTELLIGENCE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

IAN K BOYD

IAN K BOYD SIDEMAN & BANCROFT LLPONE EMBARCADERO CENTERSUITE 2200SAN FRANCISCO, CA 94111

Goods and services

ClassDescriptionStatusFirst use
005Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents and assays for testing of body fluidsABANDONED—
010Medical diagnostic apparatus for testing cells, tissue and biomolecules in the nature of proteins, small molecules, cells, and nucleic acids; Medical devices for obtaining body fluid samples; Medical diagnostic instruments for the analysis of body fluids; Medical apparatus for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, endocrine disorders and genetic diseases or other tissue-based diagnostic testing, cytology and cell-based testingABANDONED—
044Medical assistance; Medical consultations; Medical counseling; Medical information; Medical servicesABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 7, 2021MAB4ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION—
Dec 7, 2021ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Dec 7, 2021OP.SOPPOSITION SUSTAINED NO. 999999—
Dec 11, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 11, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 11, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 11, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 11, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 10, 2020RGTDREINSTATEMENT GRANTED - TTAB DECISION REVERSED—
Jul 7, 2020MAB4ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION—
Jul 7, 2020ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Jul 7, 2020OP.TOPPOSITION TERMINATED NO. 999999—
Jul 7, 2020OP.SOPPOSITION SUSTAINED NO. 999999—
Jan 22, 2019OP.IOPPOSITION INSTITUTED NO. 999999—
Jan 22, 2019OPPFOPPOSITION PAPERS RECEIVED AT TTAB—
Jan 1, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 1, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 12, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 19, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 30, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 30, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 30, 2018ALIEASSIGNED TO LIE—
Oct 17, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 2, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 2, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 2, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 25, 2018DOCKASSIGNED TO EXAMINER—
May 4, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 28, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance